March 07, 2012
A California federal judge on Tuesday barred Merz Pharmaceuticals LLC from selling wrinkle-reducing drug Xeomin, just days before the Botox competitor's nationwide launch, in a bench trial over allegations the company's employees stole trade secrets from Botox maker and rival Allergan Inc.
January 30, 2012
A California federal judge on Monday indicated that Merz Pharmaceuticals LLC and seven of its employees would have to defend themselves against allegations by Allergan Inc. that they used proprietary sales data for the wrinkle-reducing drug Botox to snag clients for a rival drug.